Haemophilus Type b Conjugate Vaccine

Scheme

Ph. Eur.

ATC (Anatomical Therapeutic Chemical Classification)

J07AG01

CAS registry number (Chemical Abstracts Service)

0126161-67-9

Therapeutic Categories

Active immunisation against haemophilus influenzae type b

Bacterial vaccine

Chemical Name

Preparation of a polysaccharide, derived from a suitable strain of Haemophilus influenzaetype b, covalently bound to a carrier protein. The polysaccharide, polyribosylribitol phosphate (PrP) is a linear copolymer composed of repeated units, with a defined molecular size (Ph. Eur.)

Foreign Names

• Vaccinum haemophili stirpis b coniugatum (Latin)
• Haemophilus Typ-B-Impfstoff, konjugiert (German)
• Vaccin conjugué de l'haemophilus type b (French)
• Vacuna contra Haemophilus influenzae tipo b (Spanish)

Generic Names

• Haemophilus influenzae B antigène purifié conjugué (IS)
• Haemophilus influenzae B-Impfstoff, konjugiert (IS)
• Haemophilus influenzae B-Polysaccharid-Konjugat-Impfstoff (IS)
• Haemophilus influenzae type b conjugate vaccine (IS)
• Haemophilus-influenzae-Typ-B-Impfstoff (konjugiert) (IS)
• Hemophilus influenzae B vaccine (IS)
• Hib (IS)
• Hib vaccine (IS)
• HIB-Konjugat-Impfstoff (IS)
• Vaccino di emofilo tipo B coniugato (IS)
• Vaccinum haemophili stirpe b coniugatum (IS)
• Vaccinum haemophilus influenzae B (IS)
• Vacuna de haemophilus influenzae tipo b (IS)
• Haemophilus Type b Conjugate Vaccine (PH: BP 2018, Ph. Eur. 9)
• Haemophilus-Typ-B-Impfstoff (konjugiert) (PH: Ph. Eur. 8)
• Vaccin conjugué de l'haemophilus type b (PH: Ph. Eur. 9)
• Vaccinum haemophili stirpis b coniugatum (PH: Ph. Eur. 8)
• Haemophilus b conjugate vaccine (tetanus toxoid conjugate) (IS)
• Haemophilus influenzae B-Saccharid-Tetanus-Konjugat-Impfstoff (IS)
• Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine (IS)
• Kapsel-Polysaccharid des Hib-Bakteriums, gebunden an Tetanus-Protein (IS)
• Polysaccharide capsulaire purifié de la bactérie Hib, lié à la protéine tétanique (IS)

Brand Names

• Acet-HIB
  Sanofi Aventis, Pakistan
• ACT-HIB
  Aventis Pasteur, Kuwait; Nijz, Slovenia; Sanofi, Sweden; Sanofi Aventis, Pakistan; Sanofi Belgium, Belgium; Sanofi Pasteur, Cyprus; Sanofi Pasteur, Macedonia; Sanofi Pasteur MSD, Greece
• Act-HIB
  Dr. Fisher Farma, Netherlands; Euro Registratie, Netherlands; Sanofi Pasteur, Poland; Sanofi Pasteur, Uruguay; Sanofi Pasteur Europe, Iceland; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Serbia
• Act-Hib
  Sanofi Pasteur MSD, Netherlands
• Act-Hib [pediatric]
  Sanofi Pasteur, Israel; Sanofi Pasteur, Paraguay
• ACT-HIB 10 µg/0,5 ml
  Sanofi Pasteur, France
• Comvax [+ Hepatitis B]
  Merck Sharp & Dohme, Mexico
• He Er Bei
  Lanzhou Bio, China
• Hiberix
  GlaxoSmithKline Biologicals, Serbia
• Hiberix [pediatric]
  GlaxoSmithKline Australia, Australia
• Likit Pedvaxhib
  MSD Merck Sharp & Dohme, Turkey
• Menitorix [+ Meningococcal Group C Polysaccharide Conjugate Vaccine]
  GlaxoSmithKline, Ireland; GlaxoSmithKline, Poland; GlaxoSmithKline Australia, Australia; GlaxoSmithKline UK, United Kingdom
• PedvaxHIB
  Cibeles, Uruguay; Merck Sharp & Dohme, Mexico
• PedvaxHIB (Merck Sharp & Dohme
  China MSD, China
• PedvaxHIB [pediatric]
  Merck Sharp & Dohme Corp., United States
• Synflorix
  GlaxoSmithKline, Chile; GlaxoSmithKline, Myanmar
• Vaxem Hib
  Novartis Healthcare, Philippines; Novartis Vaccines, Thailand; Novartis Vaccines & Diag., Italy
• actHIB
  Sanofi, Japan; Sanofi Pasteur, South Korea; Sanofi Pasteur, United States
• ACT-HIB
  Sanofi Belgium, Luxembourg; Sanofi Pasteur, Argentina; Sanofi Pasteur, Bosnia & Herzegowina; Sanofi Pasteur, Italy; Sanofi Pasteur, Norway; Sanofi Pasteur, Philippines; Sanofi-Pasteur, Colombia
• Act-HIB
  Sanofi Pasteur, Austria; Sanofi Pasteur, Canada; Sanofi Pasteur, Lithuania; Sanofi Pasteur, Russian Federation; Sanofi Pasteur MSD, Spain; Sanofi-Aventis, Australia; Sanofi-Aventis, Hong Kong
• Act-Hib [pediatric]
  Sanofi-Pasteur, China
• Hiberix
  GlaxoSmithKline, Bulgaria; GlaxoSmithKline, Spain; GlaxoSmithKline, Israel; GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Macedonia; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Singapore; GlaxoSmithKline, Turkey; GlaxoSmithKline A.B.E.E., Greece; Glaxosmithkline Biologicals, Cyprus; GSK, Czech Republic; GSK, Peru; Smith Kline & French, Portugal; Wellcome Limited, Bosnia & Herzegowina; GlaxoSmithKline China Investment, China
• Hiberix [pediatric]
  Beecham, Malta; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Ireland; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Poland; GlaxoSmithKline, Thailand; GlaxoSmithKline Biologicals, United States; GSK, Pakistan
• Pentaxim
  Sanofi-Pasteur, Colombia

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer